| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.006 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.085 | 0.007 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.007 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.2 | 0.007 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.008 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.099 | 0.008 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.009 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.009 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.085 | 0.01 |